NEOG on Nasdaq

NeoGen

Logo: Neogen, PD, via Wikipedia4

International food safety company

Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 18, 2026.

Overview

$870.4MRevenue, fiscal 20265
-$7.9MNet income, fiscal 20265
1981Founded1

Compare with Myriad Genetics, Lantheus Holdings, Inc. or Quidel, or pick any stock.

  • TickerNEOG on Nasdaq1
  • IndustryIn Vitro & In Vivo Diagnostic Substances1
  • HeadquartersAnderlecht1
  • Websitewww.neogen.com
  • Incorporated inMI6
  • Business address620 Lesher Place, Lansing, Mi 489126
  • Filer categoryLarge accelerated filer6

See how the biggest companies compare on our leaderboards

Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

46.9%Gross margin5
-2.5%Operating margin5
-0.9%Net margin5
-2.7%Revenue growth, 20265
-0.4%Return on equity5
0.38×Debt to equity5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 88% of the revenue NeoGen broke down this way in fiscal 2026.

  1. Product$768.2M588%down 4% from 2025
  2. Service$102.2M512%up 5% from 2025
Products and services by year
Products and services202420252026
Product$821.8M$797.4M$768.2M
Service$102.4M$97.3M$102.2M

Business segments

Food Safety brought in 74% of the revenue NeoGen broke down this way in fiscal 2026.

  1. Food Safety$641.1M574%up 0% from 2025
  2. Animal Safety$229.3M526%down 11% from 2025
Business segments by year
Business segments202420252026
Food Safety$655.3M$638.1M$641.1M
Animal Safety$268.9M$256.6M$229.3M

Regions

Outside the United States brought in 51% of the revenue NeoGen broke down this way in fiscal 2026.

  1. Outside the United States$445.3M551%down 1% from 2025
  2. United States$425.1M549%down 5% from 2025
Regions by year
Regions202420252026
Outside the United States$459.0M$448.7M$445.3M
United States$465.2M$446.0M$425.1M

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue53¢$461.9M
  • Research and development2¢$18.4M
  • Other costs42¢$364.9M
  • Interest3¢$24.1M
  • Income tax0¢$1.1M

Out of $870.4M in revenue.5 The company lost money this year.

Where each dollar of operating cash went, fiscal 2026

  • Kept or used elsewhere100¢$83.2M

Out of $83.2M of cash from operations.5

Financial statements

Revenue891011125$870.4M in 2026+110% since 2019
0$250.0M$500.0M$750.0M$1.0B2019: $414.2M$414.2M20192020: $418.2M$418.2M2020+1%2021: $468.5M$468.5M2021+12%2022: $527.2M$527.2M2022+13%2023: $822.4M$822.4M2023+56%2024: $924.2M$924.2M2024+12%2025: $894.7M$894.7M2025−3%2026: $870.4M$870.4M2026−3%
Gross profit891011125$408.5M in 2026+113% since 2019
0$200.0M$400.0M$600.0M2019: $191.9M$191.9M20192020: $196.3M$196.3M2020+2%2021: $215.1M$215.1M2021+10%2022: $243.0M$243.0M2022+13%2023: $406.0M$406.0M2023+67%2024: $463.9M$463.9M2024+14%2025: $421.4M$421.4M2025−9%2026: $408.5M$408.5M2026−3%
Operating income891011125-$21.6M in 2026
-$1.5B-$1.0B-$500.0M0$500.0M2019: $68.1M$68.1M20192020: $67.5M$67.5M2020−1%2021: $74.2M$74.2M2021+10%2022: $58.6M$58.6M2022−21%2023: $37.5M$37.5M2023−36%2024: $58.6M$58.6M2024+56%2025: -$1.1B-$1.1B20252026: -$21.6M-$21.6M2026−98%
Net income891011125-$7.9M in 2026
-$1.5B-$1.0B-$500.0M0$500.0M2019: $60.2M$60.2M20192020: $59.5M$59.5M2020−1%2021: $60.9M$60.9M2021+2%2022: $48.3M$48.3M2022−21%2023: -$22.9M-$22.9M20232024: -$9.4M-$9.4M2024−59%2025: -$1.1B-$1.1B2025+11517%2026: -$7.9M-$7.9M2026−99%

Every line of the income statement as filed: the last 3 fiscal years, latest first.5

Period ending2026-05-312025-05-312024-05-31
Total Revenues$870.4M$894.7M$924.2M
Total Cost of Revenues$461.9M$473.3M$460.3M
Gross Profit$408.5M$421.4M$463.9M
Sales and marketing$166.6M$183.8M$182.9M
General and administrative$245.1M$218.2M$199.9M
Goodwill impairment$0$1.1B$0
Research and development$18.4M$21.1M$22.5M
Total Operating Expenses$430.1M$1.5B$405.3M
Operating (Loss) Income-$21.6M-$1.1B$58.6M
Interest expense, net-$57.6M-$68.5M-$67.0M
Gain on sale of business$76.4M$0$0
Other, net-$6.2M-$3.6M-$5.9M
Total Other Income (Expense)$12.6M-$72.1M-$72.9M
Loss Before Taxes-$9.0M-$1.1B-$14.3M
Income Tax Benefit-$1.1M-$41.1M-$4.9M
Net Loss-$7.9M-$1.1B-$9.4M
Basic-$0.04-$5.03-$0.04
Diluted-$0.04-$5.03-$0.04
Basic217.5M shares216.9M shares216.5M shares
Diluted217.5M shares216.9M shares216.5M shares

Compare NeoGen with another company

The story

The company was founded by Herbert D. "Ted" Doan and James L. Herbert in 1981 as an investment project by Michigan State University. An early $50,000 investment by the Michigan State University Foundation awarded 30% of the company shares in the early years after its founding. The purpose of the company was to help strengthen the biotechnology community in Lansing and the state as a whole, which had no large biotech companies at the time, and to help retain molecular biologists within the state. One of the earliest acquisitions for the company was Ideal Instruments Inc. in 1985 in order to utilize their production of veterinary tools.

In 1991, Neogen purchased WTT, a 1988 spinoff company of the University of Kentucky that licensed the technology the college had developed. Named for the company's founding professors David Watt, Hsin-Hsiung "Daniel" Tai, and Thomas Tobin, WTT manufactured drug-detection tests for the horse racing industry. The ELISA (enzyme-linked immunoassay) tests allowed officials to test for performance-enhancing drugs that were difficult to detect in 1988.

In 2010, Neogen acquired the genomics-focused company GeneSeek in order to expand their focus on animal genomes and proper heredity and breeding, especially in regards to cattle.

In December 2021, 3M announced that it would merge its food-safety business with Neogen. The deal, with an enterprise value of about $5.3 billion, closed in September 2022.

From Wikipedia’s article on Neogen, shared under CC BY-SA 4.0.7

Leadership

Who has led NeoGen, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. James L. Herbert2006–2017
  2. John Edward Adent2017–2025
  3. Mikheal Nassif2025–now

Chair

  1. James L. Herbert2006–2018

President

  1. James L. Herbert2006–2007
  2. Lon M. Bohannon2006–2013
  3. Stephen K. Snyder2013
  4. Richard E. Calk Jr.2014–2016
  5. John Edward Adent2018–2023

Chief financial officer

  1. Richard R. Current2006–2010
  2. Steven J. Quinlan2011–2022
  3. David H. Naemura2022–2025
  4. Richard Bryan Riggsbee2025–now

Chief operating officer

  1. Lon M. Bohannon2006–2013
  2. James L. Herbert2006–2009
  3. Stephen K. Snyder2013–2014
  4. Richard E. Calk Jr.2014–2016
1990200020102020
Board members and other officers (38)

Products and brands

Neogen focuses on supplying products for bacterial detection and proper sterilization and tool handling with antibiotics, along with genomics research products focused on gene isolation and heredity mapping. The detection products include Reveal for Salmonella Enteriditis, along with Agri-Screen and Veratox for a range of mycotoxin detections. Advancements in hydrophobic grid membrane filter (HGMF) technology led Neogen to the creation of a disposable filter in 2004 called NEO-GRID.

From Wikipedia’s article on Neogen, shared under CC BY-SA 4.0.7

Timeline

  1. Aug 19, 2025New chief executive Mikheal Nassif becomes CEO18
  2. Jul 25, 2017New chief executive John Edward Adent becomes CEO19
  3. Apr 3, 2006New chief executive James L. Herbert becomes CEO20
  4. Dec 9, 1991Parent Directly consolidated by A.FORALL DEVELOPMENT67
  5. 1981Founded Founded1

Filings

430 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 66 major events, 234 insider forms, 36 large holders, 74 other. The latest 20:

  1. Oct 9, 20264 PRIMARY DOCUMENT EDGAR
  2. Oct 7, 202610-Q EDGAR
  3. Oct 7, 20268-K EDGAR
  4. Oct 6, 20268-K EDGAR
  5. Oct 2, 20264 PRIMARY DOCUMENT EDGAR
  6. Oct 2, 20264 PRIMARY DOCUMENT EDGAR
  7. Oct 2, 20264 PRIMARY DOCUMENT EDGAR
  8. Oct 2, 20264 PRIMARY DOCUMENT EDGAR
  9. Oct 2, 20264 PRIMARY DOCUMENT EDGAR
  10. Oct 2, 20264 PRIMARY DOCUMENT EDGAR
  11. Oct 2, 20264 PRIMARY DOCUMENT EDGAR
  12. Oct 2, 20264 PRIMARY DOCUMENT EDGAR
  13. Sep 28, 2026DEFA14A EDGAR
  14. Aug 21, 2026ARS EDGAR
  15. Aug 21, 2026DEFA14A EDGAR
  16. Aug 21, 2026DEF 14A EDGAR
  17. Aug 20, 20264 PRIMARY DOCUMENT EDGAR
  18. Aug 20, 20264 PRIMARY DOCUMENT EDGAR
  19. Aug 14, 20264 PRIMARY DOCUMENT EDGAR
  20. Aug 14, 20264 PRIMARY DOCUMENT EDGAR

The 430 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 36 such filings since October 2021, the latest 10:

  1. Jul 7, 2026SCHEDULE 13G
  2. May 14, 2026SCHEDULE 13G/A
  3. Apr 30, 2026SCHEDULE 13G
  4. Apr 29, 2026SCHEDULE 13G
  5. Mar 27, 2026SCHEDULE 13G/A
  6. Feb 17, 2026SCHEDULE 13G/A
  7. Nov 13, 2025SCHEDULE 13G/A
  8. Aug 14, 2025SCHEDULE 13G
  9. Aug 13, 2025SCHEDULE 13G
  10. Jul 30, 2025SCHEDULE 13G/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.33,431,015$300.5M0.0%+810,010
Neuberger Berman Group LLC16,570,795$149.0M0.1%+8,819,077
Vanguard Portfolio Management LLC13,038,732$117.2M0.0%+206,468
Dimensional Fund Advisors LP9,828,174$88.4M0.0%+696,153
Vanguard Capital Management LLC9,655,248$86.8M0.0%+90,202
Ing Groep Nv9,102,300$81.8M0.4%+198,000
State Street Corp8,946,377$80.4M0.0%+356,033
Gates Capital Management, Inc.8,742,274$78.6M2.6%+2,483,625
Hudson Bay Capital Management LP6,500,000$58.4M0.3%−180
Geode Capital Management, LLC5,832,899$52.4M0.0%+271,286
Bamco Inc /ny/5,015,968$45.1M0.1%+6,309
Morgan Stanley4,306,091$38.7M0.0%−274,336
Mizuho Markets Americas LLC4,250,000$38.2M0.7%+750,000
National Bank Of Canada /fi/4,000,000$36.0M0.0%+500,000
CIBC Bancorp USA Inc.3,549,006$31.9M0.0%−2,444,216
Cibc World Market Inc.3,500,500$31.5M0.1%−2,461,100
Healthcare Of Ontario Pension Plan Trust Fund3,488,246$31.4M0.0%+190,900
MUFG Securities EMEA plc3,320,011$29.8M0.3%−680,000
SG Capital Management LLC3,319,145$29.8M2.7%+1,182,421
Ameriprise Financial Inc3,264,965$29.4M0.0%+1,042,189
Bank Of America Corp /de/3,145,672$28.3M0.0%−1,494,862
Charles Schwab Investment Management Inc3,000,426$27.0M0.0%−53,456
Nomura Holdings Inc2,786,225$25.0M0.1%+698,183
Northern Trust Corp2,690,728$24.2M0.0%+329,449
Bnp Paribas Financial Markets2,225,991$20.0M0.0%−291,138

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

1 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Oct 13, 2020Greg Gianforte, HousePartial sale$1,001 - $15,000+186.2%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
    Wikimedia CommonsNeoGen logo by Neogen, PD
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67